Published in Lupus on January 01, 2005
Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. Clin Rev Allergy Immunol (2017) 0.75
Ecological meltdown in predator-free forest fragments. Science (2001) 9.84
Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res (1991) 9.56
Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. Euro Surveill (2009) 4.23
Genome-wide association studies establish that human intelligence is highly heritable and polygenic. Mol Psychiatry (2011) 4.16
The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell (1990) 4.12
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet (1990) 2.87
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem (2003) 2.21
Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH). Am J Hum Genet (1992) 2.09
Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation (1993) 2.05
Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood (1989) 1.80
Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum (1996) 1.78
Characterization of cry genes in a Mexican Bacillus thuringiensis strain collection. Appl Environ Microbiol (1998) 1.74
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
High prevalence of thrombophilic genotypes in patients with acute mesenteric vein thrombosis. Am J Gastroenterol (2001) 1.60
Generation of monoclonal antibodies reacting with normal and cancer cells of human breast. Cancer Res (1983) 1.60
The TB structural genomics consortium: a resource for Mycobacterium tuberculosis biology. Tuberculosis (Edinb) (2003) 1.55
Effects of pneumoperitoneum and reverse Trendelenburg position on cardiopulmonary function in morbidly obese patients receiving laparoscopic gastric banding. Eur J Anaesthesiol (2000) 1.54
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus. J Rheumatol (1998) 1.49
Granulocyte dysplasia and dysfunction, and CD11/CD18 defects in myelodysplastic syndromes. Leuk Lymphoma (1996) 1.42
Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med (1995) 1.42
Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A (1977) 1.38
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. J Thromb Haemost (2006) 1.37
Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum (2000) 1.32
Local cerebral blood flow and glucose utilization during isoflurane anesthesia in the rat. Anesthesiology (1986) 1.30
Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer (1985) 1.29
Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology (2000) 1.27
On the shape of the erythrocyte. Biophys J (1968) 1.25
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
Interaction of Sp1 with the human gamma globin promoter: binding and transactivation of normal and mutant promoters. Blood (1991) 1.19
Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid syndrome. J Immunol (1992) 1.16
Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells. Cancer Res (1983) 1.16
Drug quantitation on a benchtop liquid chromatography-tandem mass spectrometry system. J Chromatogr A (1997) 1.15
Primary but not metastatic human melanomas expressing DR antigens stimulate autologous lymphocytes. Int J Cancer (1984) 1.15
Strategies to improve adherence and acceptability of hormonal methods for contraception. Cochrane Database Syst Rev (2006) 1.14
The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells. Leukemia (2007) 1.14
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
A project to reduce the burden of diabetes in the African-American Community: Project DIRECT. J Natl Med Assoc (1998) 1.12
Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev (2006) 1.12
Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy. Br J Haematol (1984) 1.12
Cytotoxic T lymphocyte clones from peripheral blood and from tumor site detect intratumor heterogeneity of melanoma cells. Analysis of specificity and mechanisms of interaction. J Immunol (1989) 1.10
Typhoid fever in San Antonio, Texas: an outbreak traced to a continuing source. J Infect Dis (1984) 1.10
The second wave of 2009 pandemic influenza A(H1N1) in New Zealand, January-October 2010. Euro Surveill (2011) 1.09
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol (1997) 1.07
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant (2013) 1.07
Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system. Blood (1996) 1.06
Mycobacterium tuberculosis chaperonin 10 stimulates bone resorption: a potential contributory factor in Pott's disease. J Exp Med (1997) 1.06
Cellular and humoral immunity against human malignant melanoma. Int J Cancer (1971) 1.02
Clinical implications and possible association of malposition of the branch pulmonary arteries with DiGeorge syndrome and microdeletion of chromosomal region 22q11. Am J Cardiol (1997) 1.01
Clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins. J Clin Oncol (1998) 1.00
Rectification of whole cell cystic fibrosis transmembrane conductance regulator chloride current. Am J Physiol (1995) 1.00
beta 2-Glycoprotein I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum (1994) 0.99
The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009. Euro Surveill (2010) 0.99
Environmental urban lead exposure and blood lead levels in children of Mexico City. Environ Health Perspect (1995) 0.98
Cellular immunity to human breast carcinoma. Int J Cancer (1972) 0.98
Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay. Br J Cancer (1995) 0.97
Involvement of beta 2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol (1997) 0.97
Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy? J Natl Cancer Inst (1990) 0.97
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells. Oncogene (2007) 0.96
7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesthesiol (1997) 0.95
Adenosine is required for ethanol-induced heterologous desensitization. Mol Pharmacol (1989) 0.95
Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. Cancer Res (1986) 0.94
Bergeyella zoohelcum bacteremia after a dog bite. Clin Infect Dis (2001) 0.93
A simple and sensitive radioimmunoassay for adenosine. J Immunoassay (1991) 0.92
Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. J Immunol (1988) 0.92
Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: role of genetic thrombophilia. Endoscopy (2002) 0.92
Cancer procoagulant in human tumor cells: evidence from melanoma patients. Cancer Res (1986) 0.92
Breast cancer and lactation history in Mexican women. Am J Epidemiol (1996) 0.92
Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. Blood (1988) 0.92
Enzyme-linked immunosorbent assay for human pulmonary surfactant protein D. J Immunol Methods (1994) 0.92
A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. J Lipid Res (2001) 0.92
Secretion pattern, ultrastructural localization and function of extracellular matrix molecules involved in eggshell formation. Matrix Biol (2001) 0.92
The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells. Int J Cancer (1984) 0.91
Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol (2013) 0.90
Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones. J Exp Med (1986) 0.89
High-density lipoprotein inversely relates to its specific autoantibody favoring oxidation in thrombotic primary antiphospholipid syndrome. Lupus (2010) 0.89
Early responder myeloma: kinetic studies identify a patient subgroup characterized by very poor prognosis. J Clin Oncol (1989) 0.89
Pooling/bootstrap-based GWAS (pbGWAS) identifies new loci modifying the age of onset in PSEN1 p.Glu280Ala Alzheimer's disease. Mol Psychiatry (2012) 0.89
Single fiber electromyography of extraocular muscles: a sensitive method for the diagnosis of ocular myasthenia gravis. Muscle Nerve (1995) 0.89
Thrombosis in Churg-Strauss syndrome. Beyond vasculitis? Br J Rheumatol (1996) 0.88
A 50-kDa variant form of human surfactant protein D. Eur Respir J (1998) 0.88
Hybridomas expressing gammadelta T-cell receptors respond to cardiolipin and beta2-glycoprotein 1 (apolipoprotein H). Scand J Immunol (2003) 0.88
Peri-operative prophylaxis with phenytoin: dosage and therapeutic plasma levels. Acta Neurochir (Wien) (1996) 0.88
Susceptibility of chemoresistant murine and human tumor cells to lysis by interleukin 2-activated lymphocytes. Cancer Res (1988) 0.88
Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease. Atherosclerosis (1999) 0.87
Low protein Z levels and risk of occurrence of deep vein thrombosis. J Thromb Haemost (2006) 0.87
What is the "true" antigen for anticardiolipin antibodies? Lancet (1991) 0.87
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. Cancer Immunol Immunother (1986) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Anti-beta 2-glycoprotein I antibody: specificity and clinical significance. Lupus (1996) 0.87
Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding. J Immunol (1998) 0.86
beta(2)-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemostasis. Atherosclerosis (2000) 0.86